Amit Kumar, CEO, President, and Chairman of Anixa: Anixa Is Focused On The Treatment And Prevention Of Cancer And Infectious Diseases

By Jennifer Johnson Jennifer Johnson has been verified by Muck Rack's editorial team
Published on April 11, 2023

In this episode of the Grit Daily Startup Show, Sebastian Rusk interviews Dr. Amit Kumar, the CEO, President, and Chairman of Anixa Biosciences. Anixa Biosciences is a publicly traded biotechnology company focused on the development of innovative therapeutics for the treatment and prevention of cancer and infectious diseases. Dr. Kumar talks about his journey from being a physician to becoming an entrepreneur and how he started Anixa Biosciences. He also discusses the company’s recent developments, the technology they are using, and the impact they hope to make in the field of biotechnology.

See more Grit Daily Startup Show episodes.

Timestamps:

00:00 – Introduction 

01:30 – Dr. Kumar’s background and journey to becoming an entrepreneur. 

05:00 – How Anixa Biosciences started. 

08:10 – Overview of Anixa Biosciences’ recent developments 

11:20 – Technology used by Anixa Biosciences 

14:45 – How Anixa Biosciences is making an impact in the field of biotechnology. 

16:50 – Challenges faced by Anixa Biosciences 

19:50 – Advice for entrepreneurs in the biotechnology field 

21:20 – Conclusion

Notable Quotes:

  • “If you want to be an entrepreneur, you have to be able to deal with failure and deal with risk.” – Dr. Amit Kumar
  • “We’re developing technologies that can change the way cancer is detected and treated.” – Dr. Amit Kumar
  • “We are developing cutting-edge technologies that will allow us to tackle some of the most difficult problems in biotechnology.” – Dr. Amit Kumar
By Jennifer Johnson Jennifer Johnson has been verified by Muck Rack's editorial team

Jennifer Johnson is an Operations Specialist and Booking Producer at Grit Daily.

Read more

More GD News